The Veterinary Immunodiagnostics Market is expected to record a CAGR of 9.3% during the forecast period 2022–2029 to reach $2.71 billion by 2029. The growth of this market is driven by the increasing prevalence of diseases in animals, the presence of disease-specific immunodiagnostic tests, and advancements in immunodiagnostic technology.